the efficacy of nedocromil sodium ( 4 mg q.i.d . ) in the treatment of clinical asthma was initially shown in four open studies and subsequently confirmed in nine double-blind , placebo-controlled 4-12 week studies on patients with seasonal and perennial asthma .
C0886658
nedocromil sodium
C0004096
asthma